Table 2.

Treatments used (a) before first emergency room visit and (b) for the treatment of COVID-19 during admission.

Before first emergency room visit (n = 190, 23.25%)
ACE inhibitors	108 (13.22%)
Angiotensin II receptor blocker	123 (15.06%)
Aldosterone antagonist	8 (0.98%)
Anticoagulants	32 (3.92%)
Corticoids	22 (2.69%)
Immunosuppressants	21 (2.57%)
For the treatment of COVID-19 (n = 810, 99.14%)
Hydroxychloroquine/chloroquine	607 (74.30%)
Corticoids	354 (43.33%)
Tocilizumab	107 (13.10%)
Heparin	459 (56.18%)
Remdesivir	8 (0.98%)
Lopinavir/ritonavir	406 (49.69%)
Transfusion of hyperimmune plasma	9 (1.10%)